Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel P Judge

Showing results (221-230 of 260) with videos related to

Pageof 26
Sort By:
Journal of the American College of Cardiology|July 9, 2016
Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey)Mathew S Maurer, Mazen Hanna, Martha Grogan, et al.
European Heart Journal|March 7, 2014
The TMEM43 Newfoundland mutation p.S358L causing ARVC-5 was imported from Europe and increases the stiffness of the cell nucleusHendrik Milting, Bärbel Klauke, Alex Hoerby Christensen, et al.
JAMA Cardiology|March 30, 2026
Long-Term Durability of Acoramidis Efficacy in Transthyretin Amyloid Cardiomyopathy: Open-Label Extension of the ATTRibute-CM Randomized Clinical TrialPrem Soman, Sarah A M Cuddy, Julian D Gillmore, et al.
Circulation|November 18, 2024
Long-Term Efficacy and Safety of Acoramidis in ATTR-CM: Initial Report From the Open-Label Extension of the ATTRibute-CM TrialDaniel P Judge, Julian D Gillmore, Kevin M Alexander, et al.
Plos One|August 31, 2018
No major role for rare plectin variants in arrhythmogenic right ventricular cardiomyopathyEdgar T Hoorntje, Anna Posafalvi, Petros Syrris, et al.
Circulation. Genomic and Precision Medicine|February 10, 2021
Cadherin 2-Related Arrhythmogenic Cardiomyopathy: Prevalence and Clinical FeaturesAlice Ghidoni, Perry M Elliott, Petros Syrris, et al.
Circulation. Genomic and Precision Medicine|March 25, 2026
Evaluation of Women With Peripartum or Dilated Cardiomyopathy and Their First-Degree Relatives: The DCM Precision Medicine StudyEvan P Kransdorf, Rashmi Jain, Jonathan O Mead, et al.
Nature Communications|March 6, 2014
Mutations in Alström protein impair terminal differentiation of cardiomyocytesLincoln T Shenje, Peter Andersen, Marc K Halushka, et al.
Circulation. Genomic and Precision Medicine|March 28, 2025
Alcohol Exposure Among Patients With Dilated Cardiomyopathy and Their First-Degree Relatives: The DCM Precision Medicine StudyJavier Jimenez, Hanyu Ni, Stuart D Katz, et al.
Circulation. Heart Failure|March 16, 2019
Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic CardiomyopathyVictoria N Parikh, Colleen Caleshu, Chloe Reuter, et al.
Pageof 26

Showing results (221-230 of 260) with videos related to

Sort By:
Pageof 26
Journal of the American College of Cardiology|July 9, 2016
Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey)Mathew S Maurer, Mazen Hanna, Martha Grogan, et al.
European Heart Journal|March 7, 2014
The TMEM43 Newfoundland mutation p.S358L causing ARVC-5 was imported from Europe and increases the stiffness of the cell nucleusHendrik Milting, Bärbel Klauke, Alex Hoerby Christensen, et al.
JAMA Cardiology|March 30, 2026
Long-Term Durability of Acoramidis Efficacy in Transthyretin Amyloid Cardiomyopathy: Open-Label Extension of the ATTRibute-CM Randomized Clinical TrialPrem Soman, Sarah A M Cuddy, Julian D Gillmore, et al.
Circulation|November 18, 2024
Long-Term Efficacy and Safety of Acoramidis in ATTR-CM: Initial Report From the Open-Label Extension of the ATTRibute-CM TrialDaniel P Judge, Julian D Gillmore, Kevin M Alexander, et al.
Plos One|August 31, 2018
No major role for rare plectin variants in arrhythmogenic right ventricular cardiomyopathyEdgar T Hoorntje, Anna Posafalvi, Petros Syrris, et al.
Circulation. Genomic and Precision Medicine|February 10, 2021
Cadherin 2-Related Arrhythmogenic Cardiomyopathy: Prevalence and Clinical FeaturesAlice Ghidoni, Perry M Elliott, Petros Syrris, et al.
Circulation. Genomic and Precision Medicine|March 25, 2026
Evaluation of Women With Peripartum or Dilated Cardiomyopathy and Their First-Degree Relatives: The DCM Precision Medicine StudyEvan P Kransdorf, Rashmi Jain, Jonathan O Mead, et al.
Nature Communications|March 6, 2014
Mutations in Alström protein impair terminal differentiation of cardiomyocytesLincoln T Shenje, Peter Andersen, Marc K Halushka, et al.
Circulation. Genomic and Precision Medicine|March 28, 2025
Alcohol Exposure Among Patients With Dilated Cardiomyopathy and Their First-Degree Relatives: The DCM Precision Medicine StudyJavier Jimenez, Hanyu Ni, Stuart D Katz, et al.
Circulation. Heart Failure|March 16, 2019
Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic CardiomyopathyVictoria N Parikh, Colleen Caleshu, Chloe Reuter, et al.
Pageof 26